CN109735819B - 具有NO催化释放与EPCs捕获功能的生物材料及其制备方法 - Google Patents
具有NO催化释放与EPCs捕获功能的生物材料及其制备方法 Download PDFInfo
- Publication number
- CN109735819B CN109735819B CN201910194707.3A CN201910194707A CN109735819B CN 109735819 B CN109735819 B CN 109735819B CN 201910194707 A CN201910194707 A CN 201910194707A CN 109735819 B CN109735819 B CN 109735819B
- Authority
- CN
- China
- Prior art keywords
- epcs
- alkynylated
- functions
- capture
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000003197 catalytic effect Effects 0.000 title claims abstract description 67
- 239000012620 biological material Substances 0.000 title claims abstract description 62
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 210000001956 EPC Anatomy 0.000 title claims description 91
- 239000000463 material Substances 0.000 claims abstract description 67
- -1 azido phenol compound Chemical class 0.000 claims abstract description 35
- 125000000304 alkynyl group Chemical group 0.000 claims abstract description 29
- 238000000151 deposition Methods 0.000 claims abstract description 28
- 229910044991 metal oxide Inorganic materials 0.000 claims abstract description 24
- 150000004706 metal oxides Chemical class 0.000 claims abstract description 24
- 238000002791 soaking Methods 0.000 claims abstract description 17
- 239000000758 substrate Substances 0.000 claims abstract description 10
- 150000001540 azides Chemical class 0.000 claims abstract description 7
- 239000000243 solution Substances 0.000 claims description 62
- 238000000034 method Methods 0.000 claims description 47
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 claims description 37
- 238000006243 chemical reaction Methods 0.000 claims description 37
- 229960004502 levodopa Drugs 0.000 claims description 37
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 21
- 239000001301 oxygen Substances 0.000 claims description 21
- 229910052760 oxygen Inorganic materials 0.000 claims description 21
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 16
- FDKWRPBBCBCIGA-UWTATZPHSA-N D-Selenocysteine Natural products [Se]C[C@@H](N)C(O)=O FDKWRPBBCBCIGA-UWTATZPHSA-N 0.000 claims description 13
- 239000007853 buffer solution Substances 0.000 claims description 13
- ZKZBPNGNEQAJSX-UHFFFAOYSA-N selenocysteine Natural products [SeH]CC(N)C(O)=O ZKZBPNGNEQAJSX-UHFFFAOYSA-N 0.000 claims description 13
- 229940055619 selenocysteine Drugs 0.000 claims description 13
- 235000016491 selenocysteine Nutrition 0.000 claims description 13
- FDKWRPBBCBCIGA-REOHCLBHSA-N (2r)-2-azaniumyl-3-$l^{1}-selanylpropanoate Chemical compound [Se]C[C@H](N)C(O)=O FDKWRPBBCBCIGA-REOHCLBHSA-N 0.000 claims description 11
- 238000001755 magnetron sputter deposition Methods 0.000 claims description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 8
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 8
- 230000035484 reaction time Effects 0.000 claims description 8
- 239000007983 Tris buffer Substances 0.000 claims description 6
- 238000012986 modification Methods 0.000 claims description 6
- 230000004048 modification Effects 0.000 claims description 6
- 229920001184 polypeptide Polymers 0.000 claims description 6
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 6
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 6
- 239000008351 acetate buffer Substances 0.000 claims description 5
- YBCVMFKXIKNREZ-UHFFFAOYSA-N acoh acetic acid Chemical compound CC(O)=O.CC(O)=O YBCVMFKXIKNREZ-UHFFFAOYSA-N 0.000 claims description 5
- RTIXKCRFFJGDFG-UHFFFAOYSA-N Chrysin Natural products C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=CC=C1 RTIXKCRFFJGDFG-UHFFFAOYSA-N 0.000 claims description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 4
- 239000006184 cosolvent Substances 0.000 claims description 4
- 239000008055 phosphate buffer solution Substances 0.000 claims description 4
- NYCXYKOXLNBYID-UHFFFAOYSA-N 5,7-Dihydroxychromone Natural products O1C=CC(=O)C=2C1=CC(O)=CC=2O NYCXYKOXLNBYID-UHFFFAOYSA-N 0.000 claims description 3
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 claims description 3
- LNTHITQWFMADLM-UHFFFAOYSA-N anhydrous gallic acid Natural products OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 claims description 3
- 229940043370 chrysin Drugs 0.000 claims description 3
- 235000015838 chrysin Nutrition 0.000 claims description 3
- 229960003067 cystine Drugs 0.000 claims description 3
- 235000004515 gallic acid Nutrition 0.000 claims description 3
- 229940074391 gallic acid Drugs 0.000 claims description 3
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 claims description 2
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 claims description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N Dopamine Natural products NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 claims description 2
- 239000001263 FEMA 3042 Substances 0.000 claims description 2
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims description 2
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims description 2
- 108091034117 Oligonucleotide Proteins 0.000 claims description 2
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 claims description 2
- 102000016549 Vascular Endothelial Growth Factor Receptor-2 Human genes 0.000 claims description 2
- 108010053099 Vascular Endothelial Growth Factor Receptor-2 Proteins 0.000 claims description 2
- 235000018417 cysteine Nutrition 0.000 claims description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 2
- 229960003638 dopamine Drugs 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- 235000015523 tannic acid Nutrition 0.000 claims description 2
- 229920002258 tannic acid Polymers 0.000 claims description 2
- 229940033123 tannic acid Drugs 0.000 claims description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- BJHCYTJNPVGSBZ-YXSASFKJSA-N 1-[4-[6-amino-5-[(Z)-methoxyiminomethyl]pyrimidin-4-yl]oxy-2-chlorophenyl]-3-ethylurea Chemical compound CCNC(=O)Nc1ccc(Oc2ncnc(N)c2\C=N/OC)cc1Cl BJHCYTJNPVGSBZ-YXSASFKJSA-N 0.000 claims 1
- AXJLEYVRLPNPGF-UHFFFAOYSA-N 3-(2-carboxyethyldiselanyl)propanoic acid Chemical compound OC(=O)CC[Se][Se]CCC(O)=O AXJLEYVRLPNPGF-UHFFFAOYSA-N 0.000 claims 1
- HDSPYBVYZPTQOX-UHFFFAOYSA-N 3-azidobenzene-1,2-diol Chemical compound OC1=CC=CC(N=[N+]=[N-])=C1O HDSPYBVYZPTQOX-UHFFFAOYSA-N 0.000 claims 1
- PAZKJJDRYXKVIB-UHFFFAOYSA-N 5-azido-3-hydroxy-2-phenylchromen-4-one Chemical class O1C2=CC=CC(N=[N+]=[N-])=C2C(=O)C(O)=C1C1=CC=CC=C1 PAZKJJDRYXKVIB-UHFFFAOYSA-N 0.000 claims 1
- 108091023037 Aptamer Proteins 0.000 claims 1
- WZLGFZHLDXBDOH-DKWTVANSSA-N NCC(=O)O.N[C@@H](C[SeH])C(=O)O Chemical compound NCC(=O)O.N[C@@H](C[SeH])C(=O)O WZLGFZHLDXBDOH-DKWTVANSSA-N 0.000 claims 1
- UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical compound NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 claims 1
- 229960003151 mercaptamine Drugs 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 238000011065 in-situ storage Methods 0.000 abstract description 6
- 230000035755 proliferation Effects 0.000 abstract description 4
- 230000010100 anticoagulation Effects 0.000 abstract description 3
- 210000002460 smooth muscle Anatomy 0.000 abstract description 3
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 36
- 239000010408 film Substances 0.000 description 25
- 230000008021 deposition Effects 0.000 description 21
- 238000004544 sputter deposition Methods 0.000 description 15
- NVIVJPRCKQTWLY-UHFFFAOYSA-N cobalt nickel Chemical compound [Co][Ni][Co] NVIVJPRCKQTWLY-UHFFFAOYSA-N 0.000 description 8
- 238000007664 blowing Methods 0.000 description 7
- 238000004140 cleaning Methods 0.000 description 7
- 239000008367 deionised water Substances 0.000 description 7
- 229910021641 deionized water Inorganic materials 0.000 description 7
- 238000001035 drying Methods 0.000 description 7
- 239000010410 layer Substances 0.000 description 7
- 239000011259 mixed solution Substances 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 238000002513 implantation Methods 0.000 description 5
- 238000002294 plasma sputter deposition Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 4
- 208000007536 Thrombosis Diseases 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 238000001878 scanning electron micrograph Methods 0.000 description 4
- 239000010409 thin film Substances 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- 239000002473 artificial blood Substances 0.000 description 3
- 238000012650 click reaction Methods 0.000 description 3
- 210000002889 endothelial cell Anatomy 0.000 description 3
- 230000003511 endothelial effect Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 208000037803 restenosis Diseases 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 238000007306 functionalization reaction Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- XQMOXBYEMLHTGC-UHFFFAOYSA-N [N-]=[N+]=[N-].C=1(O)C(O)=CC=CC1 Chemical compound [N-]=[N+]=[N-].C=1(O)C(O)=CC=CC1 XQMOXBYEMLHTGC-UHFFFAOYSA-N 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- IVRMZWNICZWHMI-UHFFFAOYSA-N azide group Chemical group [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000002138 osteoinductive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Landscapes
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (27)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910194707.3A CN109735819B (zh) | 2019-03-14 | 2019-03-14 | 具有NO催化释放与EPCs捕获功能的生物材料及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910194707.3A CN109735819B (zh) | 2019-03-14 | 2019-03-14 | 具有NO催化释放与EPCs捕获功能的生物材料及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109735819A CN109735819A (zh) | 2019-05-10 |
CN109735819B true CN109735819B (zh) | 2020-01-31 |
Family
ID=66370423
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910194707.3A Active CN109735819B (zh) | 2019-03-14 | 2019-03-14 | 具有NO催化释放与EPCs捕获功能的生物材料及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109735819B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112920254B (zh) * | 2020-02-14 | 2023-06-13 | 西南交通大学 | 抗凝的功能分子、螯合物及其应用、仿生功能材料及其制备方法 |
CN113144290B (zh) * | 2020-09-09 | 2022-08-23 | 苏州大学附属第一医院 | 一种促成骨和免疫调节的骨科材料表面涂层及其制备方法 |
CN112891642A (zh) * | 2021-01-27 | 2021-06-04 | 文军 | 一种生物因子涂层支架及其制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050019404A1 (en) * | 2003-06-30 | 2005-01-27 | Hsing-Wen Sung | Drug-eluting biodegradable stent |
ITMI20061726A1 (it) * | 2006-09-11 | 2008-03-12 | Fidia Farmaceutici | Derivati crosslinkati a base di acido ialuronico reticolato via click chemistry |
US8236341B2 (en) * | 2009-04-02 | 2012-08-07 | Medtronic Vascular, Inc. | Poly(tetrafluoroethylene) polymer with nitric oxide donating surface |
EP2508212A1 (en) * | 2011-04-05 | 2012-10-10 | Universitätsklinikum Freiburg | Biocompatible and biodegradable gradient layer system for regenerative medicine and for tissue support |
CN104225675B (zh) * | 2014-08-12 | 2016-10-05 | 西南交通大学 | 一种具有一氧化氮(no)催化活性的材料的制备方法 |
CN104673096B (zh) * | 2014-08-12 | 2017-05-17 | 西南交通大学 | 一种具有一氧化氮(no)催化活性的涂层的制备方法 |
CN104758985B (zh) * | 2015-03-20 | 2017-10-24 | 西南交通大学 | 一种捕获内皮祖细胞EPCs的新型抗凝血支架涂层的制备方法 |
CN107335093A (zh) * | 2017-08-18 | 2017-11-10 | 四川大学 | 具有表面定向功能修饰涂层的多孔支架及其制备方法 |
-
2019
- 2019-03-14 CN CN201910194707.3A patent/CN109735819B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN109735819A (zh) | 2019-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109735819B (zh) | 具有NO催化释放与EPCs捕获功能的生物材料及其制备方法 | |
Xiao et al. | A versatile surface bioengineering strategy based on mussel-inspired and bioclickable peptide mimic | |
JP4284187B2 (ja) | 表面コーティング方法およびコーティングされたデバイス | |
US10729821B1 (en) | Method for preparing chitosan/heparinized graphene oxide composite multilayer film on surface of medical magnesium alloy | |
US6013106A (en) | Medical article with adhered antimicrobial metal ions and related methods | |
JP3485264B2 (ja) | 生理活性物質が結合された生体適合性医療用金属材料及びその製造方法 | |
Chen et al. | Immobilization of serum albumin and peptide aptamer for EPC on polydopamine coated titanium surface for enhanced in-situ self-endothelialization | |
JPH10513378A (ja) | ヒアルロン酸、その誘導体、および半合成ポリマーで物体を被覆する方法 | |
Zhang et al. | A nitric oxide-eluting and REDV peptide-conjugated coating promotes vascular healing | |
EP3782661B1 (en) | Polydopamine film and preparation method and use thereof | |
CN104028434B (zh) | 一种在钛表面构建层粘连蛋白/肝素/SDF-1α抗凝及诱导内皮化多功能层的方法 | |
Yao et al. | Platelet adhesion-resistance of titanium substrate with mussel-inspired adhesive polymer bearing phosphorylcholine group | |
AU2015316192B2 (en) | Medical devices with reduced thrombogenicity | |
Weng et al. | Immobilization of bovine serum albumin on TiO2 film via chemisorption of H3PO4 interface and effects on platelets adhesion | |
Pan et al. | Facile fabrication of biodegradable endothelium-mimicking coatings on bioabsorbable zinc-alloy stents by one-step electrophoretic deposition | |
Hsieh et al. | Comparison of plasma and chemical modifications of poly-L-lactide-co-caprolactone scaffolds for heparin conjugation | |
CN111035485A (zh) | 一种血管支架及其制备方法和应用 | |
Lee et al. | Improved blood compatibility and decreased VSMC proliferation of surface-modified metal grafted with sulfonated PEG or heparin | |
CN111246895B (zh) | 一种用于医用植入物表面改性的组合物以及由此表面改性的医用植入物 | |
WO2012121507A2 (ko) | 혈관내피 전구세포를 선택적으로 포획할 수 있는 스텐트 및 이의 제조 방법 | |
Li et al. | Tellurium-containing polymer coating with glutathione peroxidase mimics capability for surface modification of intravascular implants | |
CN110237312A (zh) | 一种可降解的载miRNAs纳米复合涂层及其制备方法和应用 | |
CN115814168A (zh) | 一种以聚多巴胺涂层为载体的医用钛合金器件及其制备方法 | |
CN112843343A (zh) | 血液接触类功能材料、其制备方法及应用 | |
TW201709937A (zh) | 增進生醫金屬基材血液相容性之表面修飾方法及表面修飾結構 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Yang Zhilu Inventor after: Hao Rui Inventor after: Pan Guoqing Inventor after: Huang Nan Inventor after: Tu Qiufen Inventor after: Xiong Kaiqin Inventor before: Yang Zhilu Inventor before: Pan Guoqing Inventor before: Hao Rui Inventor before: Huang Nan Inventor before: Tu Qiufen Inventor before: Xiong Kaiqin |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231111 Address after: 523039 No. 78, Wanjiang Road, Wanjiang street, Wanjiang District, Dongguan City, Guangdong Province Patentee after: DONGGUAN PEOPLE'S Hospital Address before: 610000, No. two, section 111, North Ring Road, Jinniu District, Sichuan, Chengdu Patentee before: SOUTHWEST JIAOTONG University |